Circulation

Vol. 153, Issue 3 Issue 3 2026
13
Articles

Articles in this Issue

Response by Maeng et al to Letters Regarding Article, “Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy”

Michael Maeng, Pernille G. Thrane, David Erlinge et al. Jan 20, 2026 10.1161/circulationaha.125.077511

Correction to: Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes

Nancy Song, Tariku J. Beyene, Daniel K. Amponsah et al. Jan 20, 2026 10.1161/cir.0000000000001414

ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury

Xin Chen, Xiujian Yu, Shanshan Zhong et al. Jan 20, 2026 pp. 164-184 10.1161/circulationaha.125.075220

BACKGROUND: As an iron-dependent form of regulated cell death caused by lipid peroxidation, ferroptosis has been implicated in ischemic injury, but the underlying mechanisms in acu...

Histone Lactylation–Mediated Metabolic Remodeling in Vascular Smooth Muscle Cells Aggravates Aortic Aneurysm and Dissection by Promoting Lactate Accumulation

Liwei Liu, Jinyan Zhang, Zhen Dong et al. Jan 20, 2026 pp. 189-209 10.1161/circulationaha.125.072576

BACKGROUND: Vascular smooth muscle cells (VSMCs) undergo phenotypic changes during the development of aortic aneurysm and dissection (AAD). Metabolism shifts from oxidative phospho...

Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction

Jinlong He, Yi Zhu Jan 20, 2026 pp. 185-188 10.1161/circulationaha.125.077933

Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial

Sergio Raposeiras-Roubín, Emad Abu Assi, César Jiménez Méndez et al. Jan 20, 2026 pp. 140-149 10.1161/circulationaha.125.075388

BACKGROUND: Current guidelines recommend a stepwise strategy to achieve low-density lipoprotein cholesterol (LDL-C) goals after acute coronary syndrome (ACS). Earlier intensive str...

From Race-Based to Equity-Informed Antihypertensive Medication Selection: Rationale for the 2025 AHA/ACC Guideline Change

Jordana B. Cohen, Daniel W. Jones, John M. Flack Jan 20, 2026 pp. 137-139 10.1161/circulationaha.125.077650

Letter by Pyrpyris et al Regarding Article, “Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy”

Nikolaos Pyrpyris, Kyriakos Dimitriadis, Konstantinos Tsioufis Jan 20, 2026 10.1161/circulationaha.125.076284

Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription: The NOTIFY-PICTURE Trial

Ramzi Dudum, Sneha S. Jain, Domenico Mastrodicasa et al. Jan 20, 2026 pp. 210-212 10.1161/circulationaha.125.078155

Letter by Sun Regarding Article, “Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy”

Peng Sun Jan 20, 2026 10.1161/circulationaha.125.076450

Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome

Benjamin M. Moore, Douglas Chan, Brianna Davies et al. Jan 20, 2026 pp. 154-163 10.1161/circulationaha.125.076011

BACKGROUND: The safety, yield, and prognosis of a type 1 procainamide-induced Brugada pattern are incompletely understood and may differ from those of other sodium channel blockers...

Correction to: Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial

Anping Cai, Antoni Bayés-Genís, Joanne Ryan et al. Jan 20, 2026 10.1161/cir.0000000000001413

Reassessing the First Step: Lessons From ES-BempedACS and the Era of Multi-Mechanism LDL-C Lowering

Jelani K. Grant, Thorsten M. Leucker Jan 20, 2026 pp. 150-153 10.1161/circulationaha.125.077771

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page